Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein.
暂无分享,去创建一个
D. Leprince | R. Evans | A. Leutz | S. Ansieau | R. J. Lin | R M Evans | S. Quief | O Albagli | P Dhordain | D Leprince | P. Dhordain | O. Albagli | J. Kerckaert | S Quief | J P Kerckaert | R J Lin | S Ansieau | A Leutz | R. Evans | Achim Leutz | Ronald M. Evans | J. Kerckaert | Stéphane Ansieau | Achim Leutz
[1] D. Reinberg,et al. Histone Deacetylases and SAP18, a Novel Polypeptide, Are Components of a Human Sin3 Complex , 1997, Cell.
[2] Jeffrey H. Miller. Experiments in molecular genetics , 1972 .
[3] K Offit,et al. Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. , 1993, Science.
[4] M. Boiocchi,et al. Retinoids irreversibly inhibit in vitro growth of Epstein-Barr virus-immortalized B lymphocytes. , 1996, Blood.
[5] F. Gros,et al. Myf5, MyoD, myogenin and MRF4 myogenic derivatives of the embryonic mesenchymal cell line C3H10T1/2 exhibit the same adult muscle phenotype. , 1994, Differentiation; research in biological diversity.
[6] Stuart L Schreiber,et al. Histone Deacetylase Activity Is Required for Full Transcriptional Repression by mSin3A , 1997, Cell.
[7] D. Leprince,et al. The BTB/POZ domain targets the LAZ3/BCL6 oncoprotein to nuclear dots and mediates homomerisation in vivo. , 1995, Oncogene.
[8] J. Licht,et al. Amino-terminal protein-protein interaction motif (POZ-domain) is responsible for activities of the promyelocytic leukemia zinc finger-retinoic acid receptor-alpha fusion protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[9] R S Chaganti,et al. BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[10] A. Zelent,et al. Fusion between a novel Krüppel‐like zinc finger gene and the retinoic acid receptor‐alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia. , 1993, The EMBO journal.
[11] H. Tilly,et al. LAZ3, a novel zinc–finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas , 1993, Nature Genetics.
[12] S. Fields,et al. A novel genetic system to detect proteinprotein interactions , 1989, Nature.
[13] L. Staudt,et al. Control of inflammation, cytokine expression, and germinal center formation by BCL-6. , 1997, Science.
[14] D. Leprince,et al. Small deletions occur in highly conserved regions of the LAZ3/BCL6 major translocation cluster in one case of non-Hodgkin's lymphoma without 3q27 translocation , 1997, Oncogene.
[15] K. Offit,et al. Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma. , 1994, Blood.
[16] D. Yaffe,et al. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle , 1977, Nature.
[17] R. Rousset,et al. Exclusion of Int-6 from PML Nuclear Bodies by Binding to the HTLV-I Tax Oncoprotein , 1996, Science.
[18] D. Leprince,et al. The BTB/POZ domain: a new protein-protein interaction motif common to DNA- and actin-binding proteins. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[19] P. Pandolfi,et al. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation , 1997, Nature Genetics.
[20] K. Struhl,et al. Repression by Ume6 Involves Recruitment of a Complex Containing Sin3 Corepressor and Rpd3 Histone Deacetylase to Target Promoters , 1997, Cell.
[21] F. Gros,et al. Control of myogenesis in the mouse myogenic C2 cell line by medium composition and by insulin: characterization of permissive and inducible C2 myoblasts. , 1988, Differentiation; research in biological diversity.
[22] K. Offit,et al. Frequent somatic hypermutation of the 5' noncoding region of the BCL6 gene in B-cell lymphoma. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[23] D. Leprince,et al. Multiple domains participate in distance-independent LAZ3/BCL6-mediated transcriptional repression. , 1996, Biochemical and biophysical research communications.
[24] R. Treisman,et al. The POZ domain: a conserved protein-protein interaction motif. , 1994, Genes & development.
[25] M. Ptashne,et al. A vector for expressing GAL4(1-147) fusions in mammalian cells. , 1989, Nucleic acids research.
[26] R. Eisenman,et al. Mad-max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3 , 1995, Cell.
[27] R. Evans,et al. Activation and repression by nuclear hormone receptors: hormone modulates an equilibrium between active and repressive states , 1996, Molecular and cellular biology.
[28] A. Zelent,et al. PLZF-RAR alpha fusion proteins generated from the variant t(11;17)(q23;q21) translocation in acute promyelocytic leukemia inhibit ligand-dependent transactivation of wild-type retinoic acid receptors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[29] Thorsten Heinzel,et al. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor , 1995, Nature.
[30] A. Travers,et al. The tramtrack gene encodes a Drosophila finger protein that interacts with the ftz transcriptional regulatory region and shows a novel embryonic expression pattern. , 1990, The EMBO journal.
[31] R. Chaganti,et al. Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B cell lymphoma. , 1995, The EMBO journal.
[32] C. Montell,et al. tramtrack is a transcriptional repressor required for cell fate determination in the Drosophila eye. , 1993, Genes & development.
[33] J. Manley,et al. Alternatively spliced transcripts of the Drosophila tramtrack gene encode zinc finger proteins with distinct DNA binding specificities. , 1992, The EMBO journal.
[34] R. Schiestl,et al. Improved method for high efficiency transformation of intact yeast cells. , 1992, Nucleic acids research.
[35] K. Umesono,et al. SMRT isoforms mediate repression and anti-repression of nuclear receptor heterodimers. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[36] K. Offit,et al. BCL-6 protein is expressed in germinal-center B cells. , 1995, Blood.
[37] E. Smeland,et al. All-trans- and 9-cis-retinoic acid inhibit growth of normal human and murine B cell precursors. , 1995, Journal of immunology.
[38] Wen‐Ming Yang,et al. Histone Deacetylases Associated with the mSin3 Corepressor Mediate Mad Transcriptional Repression , 1997, Cell.
[39] L. Chin,et al. An amino-terminal domain of Mxi1 mediates anti-myc oncogenic activity and interacts with a homolog of the Yeast Transcriptional Repressor SIN3 , 1995, Cell.
[40] L. Staudt,et al. Transcriptional repression by the proto-oncogene BCL-6. , 1996, Oncogene.
[41] S. Schreiber,et al. Nuclear Receptor Repression Mediated by a Complex Containing SMRT, mSin3A, and Histone Deacetylase , 1997, Cell.
[42] D. Leprince,et al. The LAZ3/BCL6 oncogene encodes a sequence-specific transcriptional inhibitor: a novel function for the BTB/POZ domain as an autonomous repressing domain. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[43] E. Jaffe,et al. Analysis of LAZ3 (BCL-6) status in B-cell non-Hodgkin's lymphomas: results of rearrangement and gene expression studies and a mutational analysis of coding region sequences. , 1995, Blood.
[44] N. Aoki,et al. Gene involved in the 3q27 translocation associated with B-cell lymphoma, BCL5, encodes a Krüppel-like zinc-finger protein. , 1994, Blood.
[45] F. Shalaby,et al. Novel zinc finger proteins that interact with the mouse gamma F-crystallin promoter and are expressed in the sclerotome during early somitogenesis. , 1994, Developmental biology.
[46] Myles Brown,et al. Polarity-specific activities of retinoic acid receptors determined by a co-repressor , 1995, Nature.
[47] C. Wu,et al. Repression of Drosophila pair-rule segmentation genes by ectopic expression of tramtrack. , 1993, Development.
[48] M. Privalsky,et al. Identification of TRACs (T3 receptor-associating cofactors), a family of cofactors that associate with, and modulate the activity of, nuclear hormone receptors. , 1996, Molecular endocrinology.